Article Figures & Data
Figures
- Figure 1
Neurological status of patients by Frankel scale.
- Figure 2
Kaplan-Meier survival curves with confidence intervals (CIs) stratified by surgery. The median overall survival of patients with decompression was 22 months (95% CI = 16–32), 3- and 5-year survival rates 30.7% and 11.2%, respectively. The median overall survival of patients with metastasectomy was 22 months (95% CI = 18–30), 3- and 5-year survival rates 28.2% and 12.8%, respectively.
- Figure 3
Kaplan-Meier survival curves with confidence intervals (CIs) stratified by adjuvant therapy. The median overall survival of patients with cytokine therapy was 18 months (95% CI = 16–24), 3- and 5-year survival rates 21% and 6.6%, respectively. The median overall survival of patients with targeted therapy was 38 months (95% CI = 27–61), 3- and 5-year survival rates 53.6% and 26.8%, respectively.
- Figure 4
Kaplan-Meier survival curves with confidence intervals (CIs) stratified by surgery. The 3- and 5-year local progression-free survival rare in patients with decompression was 76.4%. The 3- and 5-year local progression-free survival rates in patients with metastasectomy were 90.6% and 82.4%, respectively.
- Figure 5
Kaplan-Meier survival curves with confidence intervals (CIs) stratified by adjuvant therapy. The 3- and 5-year local progression-free survival rates in patients with cytokine therapy were 77.4% and 72.9%, respectively. The 3- and 5-year local progression-free survival rate in patients with targeted therapy was 95.8%.
Tables
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.